Virtu Financial LLC Plus Therapeutics, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.3 - $0.48 $4,094 - $6,550	13,647 New	13,647 $4,000
Q3 2021 Nov 12, 2021	SELL	$1.83 - $2.46 $139,422 - $187,420	-76,187 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.0 - $2.89 $152,374 - $220,180	76,187 New	76,187 $195,000
Q1 2021 May 19, 2021	SELL	$2.1 - $3.75 $38,467 - $68,692	-18,318 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$2.0 - $2.76 $7,228 - $9,974	-3,614 Reduced 16.48%	18,318 $37,000

Q3 2020 Dec 11, 2020	BUY	$2.11 - $3.17 $46,276 - $69,524	21,932 New	21,932 $56,000
Q2 2020 Aug 07, 2020	SELL	$1.43 - $2.33 $20,733 - $33,782	-14,499 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.99 - $3.23 $28,853 - $46,831	14,499 New	14,499 $35,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $50.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.